WallStreetZenWallStreetZen

NASDAQ: SLRN
Acelyrin Inc Earnings & Revenue

SLRN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$240.2M
Current Profit Margin
0%

SLRN Return on Equity

Current Company
-33.9%
Current Industry
16.8%
Current Market
30.8%
SLRN's Return on Equity (-33.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SLRN announces earnings.

SLRN Return on Assets

Current Company
-31.2%
Current Industry
3.2%
SLRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SLRN Return on Capital Employed

Current Company
-37.22%
Current Industry
-42.4%

SLRN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SLRN$0.00-$239.81M-$240.16MN/AN/A
CABA$0.00-$72.37M-$76.87MN/AN/A
NKTX$0.00-$106.61M-$116.20M-100.00%N/A
FULC$2.51M-$97.34M-$99.43M+35.25%N/A
PGEN$5.44M-$90.64M-$96.91M-47.32%N/A

Acelyrin Earnings & Revenue FAQ

What were SLRN's earnings last quarter?

Acelyrin (NASDAQ: SLRN) reported Q1 2024 earnings per share (EPS) of -$0.36, up 95.82% year over year. Total Acelyrin earnings for the quarter were -$34.97 million. In the same quarter last year, Acelyrin's earnings per share (EPS) was -$8.61.

If you're new to stock investing, here's how to buy Acelyrin stock.

What was SLRN's earnings growth in the past year?

As of Q2 2024, Acelyrin's earnings has grown year over year. Acelyrin's earnings in the past year totalled -$240.16 million.

What was SLRN's revenue last quarter?

Acelyrin (NASDAQ: SLRN) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Acelyrin's revenue was $0.00.

What was SLRN's revenue growth in the past year?

As of Q2 2024, Acelyrin's revenue has grown null year over year. Acelyrin's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.